Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00151
|
|||||
Drug Name |
Pomalidomide
|
|||||
Synonyms |
Actimid (TN); Pomalidomide (Immunomodulator)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Systemic sclerosis [ICD11: 4A42.0] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C13H11N3O4
|
|||||
Canonical SMILES |
C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
|
|||||
InChI |
InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)
|
|||||
InChIKey |
UVSMNLNDYGZFPF-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 19171-19-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 273.24 | Topological Polar Surface Area | 110 | ||
Heavy Atom Count | 20 | Rotatable Bond Count | 1 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
0.2
|
|||||
PubChem CID | ||||||
PubChem SID |
10243744
, 103100612
, 103221733
, 104253216
, 104382952
, 117621779
, 124757341
, 125164145
, 125697093
, 129427476
, 135089995
, 135727444
, 136348254
, 136367549
, 136946644
, 137009922
, 142523166
, 143499180
, 14848461
, 149539643
, 152235120
, 152258286
, 152343904
, 160647125
, 160837107
, 162011791
, 162012270
, 162037668
, 162189531
, 162856472
, 163398415
, 163778934
, 163907985
, 164194051
, 172889447
, 172889448
, 173130995
, 174007398
, 174528127
, 175424471
, 175427148
, 178103920
, 179116970
, 186007045
, 29312424
, 50086901
, 50447747
, 53787052
, 57345004
, 96025659
|
|||||
ChEBI ID |
ChEBI:72690
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Pomalidomide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (ID: DB08910) |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.